Electrotherapy Systems Market Size, Share, & Trends by 2030

Electrotherapy Systems Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product [Percutaneous Electrical Nerve Stimulation (PENS), Spinal Cord Stimulation (SCS), Transcutaneous Electrical Nerve Stimulation (TENS), Micro-Current Therapy, Interferential Current Therapy (IC), Electro-Acupuncture (EA), Pulsed Short Wave Diathermy (PSWD), Transcutaneous Spinal Electroanalgesia (TSE), and Others], Application (Neuromuscular Dysfunction, Pain Management, Acute & Chronic Edema, Sports Injury Treatment, Iontophoresis, Urine & Fecal Incontinence, and Others), and End User (Hospitals, Clinics, Long Term Care Centers, Rehabilitation Centers, and Others)

Publication Month : Feb 2024

  • Report Code : TIPHE100001378
  • Category : Medical Device
  • Status : Data Released
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

[Research Report] The electrotherapy systems market size was valued at US$ 4.21 billion in 2022 and is expected to reach US$ 8.57 billion by 2030. The market is estimated to register a CAGR of 9.3% from 2022 to 2030.

Market Insights and Analyst View:

The report includes growth prospects owing to the current electrotherapy systems market trends and their foreseeable impact during the forecast period.

An electrotherapy system is a medical device used to stimulate a patient's muscle function by passing electric currents through their tissues. Electrotherapy is useful in treating acute post-traumatic and post-surgical pain, facilitating wound healing and muscle spasm relaxation, preventing and mitigating disuse atrophy, aiding muscle rehabilitation, maintaining and increasing range of motion, and relieving acute post-traumatic and post-surgical pain. Electrotherapy units typically consist of a battery-operated device wired to adhesive electrode pads that make contact with the skin. Factors such as the increasing prevalence of sports injuries and strategic initiatives by manufacturers propel the electrotherapy systems market.

Market Drivers:

The increasing incidences of chronic diseases such as cancer, cardiovascular diseases, neurovascular diseases, and musculoskeletal diseases are likely to drive the growth of the pain management devices market. These diseases critically affect a person's health by lowering immunity and resulting in chronic pain. The incidences of chronic diseases are most commonly seen in adults and the geriatric population. For instance, according to the Centers for Disease Control and Prevention data between 2019 and 2021, the prevalence of chronic pain among US adults ranged from 20.5% to 21.8%, and high-impact chronic pain ranged from 6.9% to 7.8%. During 2021, an estimated 51.6 million US adults experienced chronic pain, and 17.1 million experienced high-impact chronic pain.

Furthermore, the incidences of chronic pain are commonly seen among athletes, sportspersons, and people living with past injuries. Chronic pain incidences increase the dependency of a person on others for various daily tasks. Therefore, pain management is essential to carry out normal daily routine. The electrotherapy systems provide relief for longer durations and also improve their health. Therefore, the increasing incidences of chronic diseases propels the electrotherapy systems market growth.

According to the report titled "Spinal Cord Injury Facts and Stats" published in July 2022, ∼17,700 Americans suffer from a spinal cord injury yearly, of which ∼78% are men with an average age of 43. As per estimates by the National Safety Council of the United States, nearly 3.2 million people in the US received treatments in emergency departments for injuries involving sports and recreational equipment in 2021. Therefore, the high incidence of spinal cord injuries propels the electrotherapy systems market growth.

The Federal Food, Drug, and Cosmetic Act includes electrical muscle stimulators (EMS) in the category of devices. The FDA is responsible for regulating the sale of all electrical muscle stimulators in the US per the legislation and the agency's rules. Thus, companies cannot lawfully sell their stimulators unless they have complied with all applicable FDA premarket regulatory procedures. The majority of electrical muscle stimulators that the FDA has evaluated are meant to be used in physical therapy and rehabilitation under a physician's supervision. Companies must demonstrate to the FDA that their EMS devices can be used in that environment both safely and effectively if they want to sell them to consumers directly. Before they can lawfully sell their products, companies that market EMS devices must adhere to the relevant FDA premarket regulatory criteria. Thus, stringent regulatory specifications for electrotherapy products limit the electrotherapy systems market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Electrotherapy Systems Market: Strategic Insights

electrotherapy-system-market
Market Size Value inUS$ 4.21 billion in 2022
Market Size Value byUS$ 8.57 billion by 2030
Growth rateCAGR of 9.3% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The electrotherapy systems market analysis has been carried out by considering the following segments: product, application, and end user.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

 

Segmental Analysis:

The electrotherapy systems market, by product, is segmented into percutaneous electrical nerve stimulation (PENS), transcutaneous electrical nerve stimulation (TENS), spinal cord stimulation (SCS), micro-current therapy, interferential current therapy (IC), electro-acupuncture (EA), pulsed short wave diathermy (PSWD), transcutaneous spinal electroanalgesia (TSE), and others. The spinal cord stimulation segment held the largest share of the market in 2022. It is likely to register the highest CAGR during 2022–2030. Spinal cord stimulation has been in use in medical facilities for years. Cervical and lumbar radiculitis, failed back surgery syndrome, complex regional pain syndrome, and neuropathy are a few of the conditions that can be assisted by the therapy. Spinal cord stimulation is an efficacious, safe, and cost-effective method of chronic pain management. Newer spinal cord stimulation technologies are being introduced to treat an extended range of clinical indications, including visceral and ischemic pain, with the potential for further improved efficacy.

Electrotherapy Systems Market, by Product – 2022 and 2030

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

By application, the market is segmented into neuromuscular dysfunction, pain management, acute and chronic edema, sports injury treatment, iontophoresis, urine and fecal incontinence, and others. The pain management segment held the largest share of the electrotherapy systems market share in 2022. It is likely to register the highest CAGR during 2022–2030. The market growth of this segment is attributed to the burgeoning prevalence of trauma and sports injuries. According to data released by the World Health Organization in March 2022, nearly 30 million children and teenagers participate in organized sports and more than 3.5 million injuries are reported every year. Furthermore, it was also estimated that 570,000 people faced traumatic pain in the US in 2021. An upsurge in the occurrence of back pain and neck pain also results in a heightened demand for electrotherapy to treat chronic pain.

By end user, the electrotherapy systems market is segmented into hospitals, clinics, long-term care centers, rehabilitation centers, and others. In 2022, the hospitals segment accounted for the largest electrotherapy systems market share.

Regional Analysis:

The scope of the electrotherapy systems market report includes North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). In terms of revenue, North America dominated the electrotherapy systems market in 2022. Population aging is a major factor that can be associated with the elevated demand for electrotherapy in the region. According to WHO data released in December 2022, 73 million individuals in North America are estimated to be of age 65 or above by 2053. The same source states that 17% of the US population above 65 years of age are experiencing back discomfort and spinal injuries.

Competitive Landscape and Key Companies:

The electrotherapy systems market report is focused on prominent players in the market. These include BTL, DJO LLC, Omron Healthcare Inc, Abbott, Boston Scientific Corporation, Medtronic, Nevro Corp, Phoenix Healthcare, Eme srl, and Pure Care. These companies focus on new technologies, upgrading existing products, and market expansions to meet the growing consumer demand worldwide. The electrotherapy systems market forecast can help stakeholders plan their growth strategies.

  • In January 2022, Medtronic plc, a global leader in healthcare technology, received approval from the US Food and Drug Administration (FDA) for its Intellis (rechargeable) and Vanta (recharge-free) neurostimulators for the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN). This new indication offers DPN patients access to Medtronic's industry-leading SCS portfolio of rechargeable and recharge-free solutions, including multiple programming options to personalize patient therapy, unrestricted MRI access, and unrivaled battery chemistry and performance, along with the Medtronic TYRX Neuro Absorbable Antibacterial Envelope.
  • In March 2021, the FDA approved an application by Medtronic plc for the revised commercial labeling for its Intellis platform with Differential Target Multiplexed (DTM) programming. The new labeling was meant to include study outcomes from a multicenter randomized control trial, mentioning superior back pain relief conferred by DTM SCS compared to conventional SCS.
  • In September 2020, Boston Scientific launched the WaveWriter Alpha portfolio of SCS systems in Europe. The four MRI conditional, Bluetooth-enabled implantable pulse generators (IPGs) launched in this portfolio offer greater personalization based on patient needs. The products also include rechargeable and non-rechargeable options, and access to waveforms covering multiple areas of pain.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Application, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is electrotherapy systems?

An electrotherapy system is a medical device used to stimulate a patient's muscle function by passing electric currents through their tissues. Electrotherapy is useful in treating acute post-traumatic and post-surgical pain, facilitating wound healing and muscle spasm relaxation, preventing and mitigating disuse atrophy, aiding muscle rehabilitation, maintaining and increasing range of motion, and relieving acute post-traumatic and post-surgical pain. Electrotherapy units typically consist of a battery-operated device wired to adhesive electrode pads that make contact with the skin.

What are the driving factors for the electrotherapy systems market across the globe?

The factors that are driving growth of the market are increasing prevalence sports injury and strategic initiative by manufacturers.

Who are the major players in the electrotherapy systems market?

The electrotherapy systems market majorly consists of the players such as BTL, DJO LLC, Omron Healthcare Inc, Abbott, Boston Scientific Corporation, Medtronic, Nevro Corp, Phoenix Healthcare, Eme srl, and Pure Car among others.

Which country is dominated the electrotherapy systems market?

US holds the largest market share in electrotherapy systems market. Approximately, 30 million children and adolescents participate in youth sports in the United States, leading to an increase in the number of sports injuries among America's young athletes. It is estimated that, More than 3.5 million kids below the age of 14 years receive medical treatment for sports injuries every year, accounting for nearly 40 percent of all sports-related injuries treated in hospitals.

Which product segment is dominating the electrotherapy systems market?

The electrotherapy systems market, based on product, is segmented into percutaneous electrical nerve stimulation (PENS), transcutaneous electrical nerve stimulation (TENS), spinal cord stimulation (SCS), micro-current therapy, interferential current therapy (IC), electro-acupuncture (EA), pulsed short wave diathermy (PSWD), transcutaneous spinal electroanalgesia (TSE), and others. The spinal cord stimulation (SCS) segment held a larger share of the market in 2022 and is likely to register a higher CAGR in the electrotherapy systems market during 2022–2030.

Which application segment is dominating the electrotherapy systems market?

The electrotherapy systems market, based on application, is segmented into neuromuscular dysfunction, pain management, acute and chronic edema, sports injury treatment, tissue repair, iontophoresis, urine and fecal incontinence, and others. The pain management segment held the largest share of the market in 2022 and is likely to register the highest CAGR in the electrotherapy systems market during 2022–2030.

Which end user segment is dominating the electrotherapy systems market?

The electrotherapy systems market, based on end user, segmented into hospitals, clinics, long-term care centers, rehabilitation centers, and others. In 2022, the hospitals segment dominated the electrotherapy systems market share and is expected to register the highest CAGR during 2022–2030.

Which region is the fastest growing the electrotherapy systems market?

Asia Pacific is expected to be the fastest growing region in the electrotherapy systems market. The electrotherapy systems market in Asia Pacific is growing due to expanding pool of patients with neurology-associated pain disorders, and the growing concerns over the prevalence of neuropathy and other related conditions, subsequently increasing in demand for electrotherapy.

The List of Companies - Electrotherapy Systems Market

  1. BTL
  2. DJO LLC.
  3. Omron Healthcare Inc.
  4. Abbott
  5. Boston Scientific Corporation
  6. Medtronic
  7. Nevro Corp.
  8. Phoenix Healthcare
  9. Eme srl
  10. Pure Care           

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Electrotherapy Systems Market